Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Y Fuchs

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
The American Journal of Pathology|November 13, 2013
HCV infection selectively impairs type I but not type III IFN signalingPartha K Chandra, Lili Bao, Kyoungsub Song, et al.
Cell Reports|April 8, 2016
Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and ProgressionYuliya V Katlinskaya, Kanstantsin V Katlinski, Qiujing Yu, et al.
The Journal of Clinical Investigation|May 27, 2015
ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasisSouvik Dey, Carly M Sayers, Ioannis I Verginadis, et al.
Cell Reports|April 30, 2015
DNA-damage-induced type I interferon promotes senescence and inhibits stem cell functionQiujing Yu, Yuliya V Katlinskaya, Christopher J Carbone, et al.
Nature Cell Biology|April 15, 2020
Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signallingSnahlata Singh, Sushil Kumar, Ratnesh Kumar Srivastava, et al.
Plos Genetics|December 16, 2016
PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in MelanomaDariusz Pytel, Yan Gao, Katarzyna Mackiewicz, et al.
Nature Cell Biology|December 13, 2017
A PERK-miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survivalYiwen Bu, Akihiro Yoshida, Nilesh Chitnis, et al.
Molecular and Cellular Biology|October 7, 2009
Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signalingJianghuai Liu, Lucas P Carvalho, Sabyasachi Bhattacharya, et al.
Cell Metabolism|September 7, 2022
ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytesZhen Lu, Noreen McBrearty, Jinyun Chen, et al.
Nature Communications|November 5, 2022
Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancerZhen Lu, Jinyun Chen, Pengfei Yu, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
The American Journal of Pathology|November 13, 2013
HCV infection selectively impairs type I but not type III IFN signalingPartha K Chandra, Lili Bao, Kyoungsub Song, et al.
Cell Reports|April 8, 2016
Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and ProgressionYuliya V Katlinskaya, Kanstantsin V Katlinski, Qiujing Yu, et al.
The Journal of Clinical Investigation|May 27, 2015
ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasisSouvik Dey, Carly M Sayers, Ioannis I Verginadis, et al.
Cell Reports|April 30, 2015
DNA-damage-induced type I interferon promotes senescence and inhibits stem cell functionQiujing Yu, Yuliya V Katlinskaya, Christopher J Carbone, et al.
Nature Cell Biology|April 15, 2020
Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signallingSnahlata Singh, Sushil Kumar, Ratnesh Kumar Srivastava, et al.
Plos Genetics|December 16, 2016
PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in MelanomaDariusz Pytel, Yan Gao, Katarzyna Mackiewicz, et al.
Nature Cell Biology|December 13, 2017
A PERK-miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survivalYiwen Bu, Akihiro Yoshida, Nilesh Chitnis, et al.
Molecular and Cellular Biology|October 7, 2009
Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signalingJianghuai Liu, Lucas P Carvalho, Sabyasachi Bhattacharya, et al.
Cell Metabolism|September 7, 2022
ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytesZhen Lu, Noreen McBrearty, Jinyun Chen, et al.
Nature Communications|November 5, 2022
Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancerZhen Lu, Jinyun Chen, Pengfei Yu, et al.
Pageof 12